Company intelligence / Profile preview

Halpern Capital

Boca Raton, Florida, USA

Ownership: Private
Development stage: Other

Overview

Halpern Capital was a boutique investment bank and institutional research firm that specialized in the healthcare and life sciences sectors. The firm provided equity research, investment banking, and advisory services to institutional investors and corporate clients, with a particular focus on small-cap and micro-cap biotechnology companies. Founded by Michael Halpern, the firm was recognized for its specialized analysis of clinical-stage drug developers and emerging medical technologies. Although it was a prominent name in biotech equity research during the 2000s, the firm is no longer an active registered broker-dealer.

Industry: Investors

Beyond the preview

Go deeper on Halpern Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Halpern Capital.

Explore the full profile